This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit April 03, 2014

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click here to view an article on the attempts to solve prescription drug abuse while protecting access for people with pain.

Check out BioDesix VeriStrat test that helps guide second line therapy in non small cell lung cancer (NSCLC).

Click here to view a press release on Medicare coverage.

Click here to view a press release on the study being included in Best of ASCO.

Get up to date information on nutrition and nutrition research from Michael Greger, M.D. at NutritionFacts.org. Click here to view the website!

Granix is now available in the fight against neutropenia during chemotherapy. Click here to view the USPI! Visit www.granixrx.com for more information.

Click here to view the following free CME/CEU program:
Non-Invasive Pre Natal Testing: What Managed Care Needs to Know

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts


Announcing the NAMCP Medical Directors Breast Cancer Resource Center. Click here to visit the website.

The Academy of Oncology Nurse Navigators white paper, "Assessing the Creative Application and Usefulness of NSider: A Tactical Tool for the Oncology Nurse Navigator" was published in the journal, The Oncology Nurse-APN/NP.

Click here to view the white paper.


 




GENOMICS

Gene therapy's big comeback
Forbes
Elliott Sigal earned a reputation at Bristol-Myers Squibb as one of the drug industry's best research chiefs. His bets on risky technologies like cancer immunotherapy and new types of diabetes drugs helped Bristol turn from a laggard into a growth stock. But there was one technology he wouldn't touch: gene therapy, which tries to use engineered viruses to defeat disease at the DNA level.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Obesity linked to genetics
MedicalDaily
Thinking of carbohydrates, many people immediately picture bread, potatoes and pasta, but carbs come in many healthy forms — whole grains, vegetables, and fruits. Carbs are a necessary part of the diet and provide the body with glucose, which is converted to energy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Ancient virus DNA gives stem cells the power to transform
National Geographic
A virus that invaded the genomes of humanity's ancestors millions of years ago now plays a critical role in the embryonic stem cells from which all cells in the human body derive, new research shows. The discovery sheds light on the role viruses play in human evolution and could help scientists better understand how to use stem cells in advanced therapies or even how to convert normal cells into stem cells.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  CEUS: RN, CCM, Safety Training

Get CEUs and Safety Training for your Nurses and Case Managers! Group rates available! CareerSmart offers online CEUs and safety training applicable for Nurses, Case Managers and other healthcare professionals. They are designed to help staff prevent work-related injuries and maintain compliance with mandated continuing education requirements.
 


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Personalized medicine requires data infrastructure, expertise
FierceHealthIT
Algorithms, artificial intelligence and machine learning increasingly will be central to personalized medicine, outlining the need for talented biocomputing and bioinformatic human expertise, writes Eric Topol, M.D., in an article at Cell. Topol, a cardiologist at the Scripps Research Institute in San Diego, discusses how genetics will be used in varying ways from preconception and throughout a patient's life.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Patients can now choose not to know their own DNA secrets
Scientific American
In 2030, Joe Johnson goes to the doctor with vision problems. The doctor does what doctors in 2030 do for almost any ailment: she runs a full scan of the patient's genome. The test gives the doctor crucial information she needs to understand Joe's troubles — and then some. When Joe gets his lab report back his doctor discovers Joe has about an 80 percent chance of developing colorectal cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Is gender a drug safety issue in the era of personalized medicine?
PharmExec
In January 2013, FDA told manufacturers to lower the dose of zolpidem, the insomnia treatment, for women, and suggested a 10 milligrams to 5 milligrams for immediate-release products (Ambien, Edluar, and Zolpimist) and from 12.5 milligrams to 6.25 milligrams for extended-release products (Ambien CR). That was based on evidence the drug is metabolized more slowly in women, which makes the side effect of next-day impairment more likely in women than men.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Stem cell scientist guilty of falsifying data
TIME
Haruko Obokata, a stem-cell scientist at the Riken Center for Developmental Biology in Kobe, Japan, has been found guilty of misconduct by a committee of investigators led by her own government-funded institute after other researchers questioned the findings.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Research report on global UCB stem cell market
News-Medical.net
Research and Markets has announced the addition of the "Global Stem Cell Umbilical Cord Blood Market — Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast to 2020" report to their offering. The study observed that the global umbilical cord blood stem cell market is forecasted to reach market value over $11.5 billion in 2014 from $6.5 billion in 2012.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


EMERGING MEDICAL TECHNOLOGIES


Mobile health market poised for growth, despite obstacles
By Pamela Lewis Dolan
The biggest challenges to widespread mobile health adoption in the U.S. are reimbursement and lack of regulatory clarification. But despite these challenges, the mobile health industry is expected to experience tremendous growth over the next few years and address many of the disparities plaguing healthcare in the U.S. This is according to a new report that looked at the mobile health market in both the U.S. and China. It found that despite the challenges the mobile health industry faces in both countries, together they will account for more than one-third of the entire world market by 2017.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Technology, smartphones will shape healthcare's future
FierceHealthcare
Many people hold the future of healthcare in their hands — or in their pockets. Smartphone technology, social media and data mining will drive change and shift the future of healthcare, said Wellpoint, Inc. Chief Executive Officer Joseph Swedish, the Malcolm T. MacEachern Memorial Lecturer at the American College of Healthcare Executives Congress in Chicago.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Becoming cyborgs: Wearable tech disrupts healthcare
Forbes
Health and healthcare have typically been a personal relationship between doctors and patients — kept private and behind closed doors. More recently, however, healthcare is being opened up by technology. Medical questions are crowdsourced, records are electronic and doctors are connected directly with their patients &mdahs; before, during, after and sometimes instead of a visit to the office.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Gene therapy's big comeback
Forbes
Elliott Sigal earned a reputation at Bristol-Myers Squibb as one of the drug industry's best research chiefs.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
1st stem cell study of bipolar disorder offers hope for better treatments
Fox News
When it comes to understanding bipolar disorder, many questions remain unanswered &mdahs; such as what truly causes the condition and why finding proper treatments is so difficult.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
How your genes help you become a good parent
TIME
Or a bad one, for that matter. A new study suggests both genetic and environmental factors determine how a parent is likely to raise a child, both positively and negatively.

Share on FacebookTwitterShare on LinkedinE-mail article
read more




MANAGED HEALTHCARE NEWS


Affordable Care Act's deadline day arrives — now what?
By Ross Lancaster
March 31 marks the last day of open enrollment under the Affordable Care Act, President Barack Obama's controversial and signature domestic policy achievement. Despite the well-publicized deadline, the White House has announced that those who have started the application process on HealthCare.gov will be granted an extension to complete the process. With a flood of last-minute applications, the day started out as something of a microcosm for the often-maligned law's rollout.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Obamacare has led to health coverage for millions more people
Los Angeles Times
President Barack Obama's healthcare law, despite a rocky rollout and determined opposition from critics, already has spurred the largest expansion in health coverage in America in half a century, national surveys and enrollment data show. As the law's initial enrollment period closes, at least 9.5 million previously uninsured people have gained coverage.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


FDA approves Biogen Idec treatment for hemophilia B
The Wall Street Journal
The U.S. Food and Drug Administration has approved Biogen Idec Inc. treatment for hemophilia B, a largely inherited disorder that is the second-most common type of hemophilia. The investigational treatment—called Alprolix—won Canadian approval earlier this month. Alprolix is also under review by regulatory authorities in several other markets, including Japan and Australia.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Alimera makes 4th bid for eye treatment approval from FDA
Reuters
Alimera Sciences Inc. said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindness in diabetes patients. Alimera said it had provided a safety update and responded to questions the U.S. Food and Drug Administration raised in October, when it rejected marketing approval for the treatment for a third time.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Building the Google of blood, 1 tube at a time (The New Yorker)
Replacing insulin through stem cell-derived pancreatic cells under the skin (Medical Xpress)
Breast cancer genes and patient protection in an era of personalized medicine (The Huffington Post)
Affordable Care Act may actually lead to fewer clinical visits (By Pamela Lewis Dolan)
Breast cancer gene may also be linked to high-risk uterine cancer (The Associated Press via Fox News)

Don't be left behind. Click here to see what else you missed.


FAST FACTS
"Seizures can be caused by a number of factors, including epilepsy or fever, and most seizures stop themselves, according to the National Institutes of Health."


 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
March 27, 2014
March 20, 2014
March 13, 2014
March 6, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063